The synthesis and vasopressin (AVP) antagonist activity of a novel series of N-aroyl-2,4,5,6-tetrahydropyrazolo[3,4-d]thieno[3,2-b]azepines

被引:26
作者
Albright, JD [1 ]
Delos Santos, EG [1 ]
Dusza, JP [1 ]
Chan, PS [1 ]
Coupet, J [1 ]
Ru, X [1 ]
Mazandarani, H [1 ]
机构
[1] Wyeth Ayerst Res, Chem Sci, Pearl River, NY 10965 USA
关键词
D O I
10.1016/S0960-894X(00)00084-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Synthesis and SAR of N-[4-[(4, 5-dihydropyrazolo[3,4-D]thieno[3,2-b]azepin-6(2H)-yl)carbonyl]phenyl]benzamides as arginine vasopressin (AVP) receptor antagonists are discussed. Potent orally active AVP receptor antagonists are produced when the benzamide moietv contains a phenyl group at the 2-position. Similar analogues of 4,6,7,8-tetrahydro-5H-thieno[3,2-b]azepine and VPA-985 are reported. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:695 / 698
页数:4
相关论文
共 28 条
[1]   5-fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985):: An orally active arginine vasopressin antagonist with selectivity for V2 receptors [J].
Albright, JD ;
Reich, MF ;
Delos Santos, EG ;
Dusza, JP ;
Sum, FW ;
Venkatesan, AM ;
Coupet, J ;
Chan, PS ;
Ru, X ;
Mazandarani, H ;
Bailey, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (14) :2442-2444
[2]  
Albright JD, 1997, CURR PHARM DESIGN, V3, P615
[3]  
ALBRIGHT JD, 1997, Patent No. 5612334
[4]  
ALBRIGHT JD, 1997, Patent No. 5696112
[5]  
ALBRIGHT JD, 1997, Patent No. 5654297
[6]  
ALBRIGHT JD, 1996, Patent No. 5532235
[7]   SYNTHESIS OF DL-DEETHYLIBOGAMINE [J].
AUGUSTINE, RL ;
PIERSON, WG .
JOURNAL OF ORGANIC CHEMISTRY, 1969, 34 (04) :1070-+
[8]  
FABRICHN.BP, 1965, DOKL AKAD NAUK SSSR+, V162, P120
[9]  
FABRICHNYI B, 1961, J GEN CHEM USSR, V31, P1152
[10]   THERAPEUTIC EFFICACY OF NONPEPTIDE ADH ANTAGONIST OPC-31260 IN SIADH RATS [J].
FUJISAWA, G ;
ISHIKAWA, SE ;
TSUBOI, Y ;
OKADA, K ;
SAITO, T .
KIDNEY INTERNATIONAL, 1993, 44 (01) :19-23